Results of the Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-Year Outcomes in Deceased Donor Kidney Transplant Recipients
P. Heeger,B. Armstrong,T. Alhamad,D. Brennan, J. Bromberg,S. Bunnapradist,S. Chandran, R. Fairchild, D. Foley,R. Formica, I. W. Gibson, D. Hricik, K. Kesler,R. B. Mannon, M. Menon,K. Newell,P. Nickerson, J. Odim, E. Poggio, R. Sung, R. Shapiro,K. Tinckam,F. Vincenti AMERICAN JOURNAL OF TRANSPLANTATION（2022）
AI 理解论文
溯源树
样例
